EuroAPI secures €130-150 million animal health contract

EuroAPI has entered into a contract manufacturing organization (CMO) agreement with a global animal health company.

As part of this collaboration, EuroAPI will provide a key veterinary product to its customers. The total contract value is expected to be between €130 million and €150 million over the period 2025-2029.

Ludwig de Mot, CEO of EuroAPI said: "The signing of this important contract ensures the long-term supply of complex chemical molecules vital to veterinary medicines. This is a real recognition of EuroAPI’s expertise and the reliability of the quality service we provide to our clients." "This agreement will be a key driver in the sales trajectory of our FOCUS-27 program."

EuroAPI has expertise in the animal health sector, with many customers and products in its portfolio, such as hormones, prostaglandins and complex synthetic molecules. Health for Animals estimates that the global animal health market will be worth US$41.8 billion in 2023 and is expected to reach US$56.8 billion by 2030, growing at a compound annual growth rate of 4.5%.